Sarepta Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
1,848.42 |
1,971.94 |
1,472.24 |
1,372.76 |
1,319.88 |
1,293.08 |
| Przychód Δ r/r |
0.00% |
6.68% |
-25.34% |
-6.76% |
-3.85% |
-2.03% |
| Przychód (min) |
1,789.42 |
1,508.34 |
948.81 |
1,342.33 |
1,000.69 |
980.36 |
| Przychód (max) |
1,877.91 |
2,161.30 |
2,236.40 |
1,403.20 |
1,601.56 |
1,569.03 |
| EBITDA (średnia) |
-768.04 |
-819.37 |
-611.73 |
-570.40 |
-548.43 |
-537.29 |
| EBIT (średnia) |
-870.85 |
-929.04 |
-693.62 |
-646.75 |
-621.84 |
-609.21 |
| EBIT % |
-47.11% |
-47.11% |
-47.11% |
-47.11% |
-47.11% |
-47.11% |
| Zysk netto (średni) |
279.90 |
-484.32 |
178.03 |
104.02 |
110.00 |
114.87 |
| Zysk netto % |
15.14% |
-24.56% |
12.09% |
7.58% |
8.33% |
8.88% |
| EPS (średnia) |
2.62 |
-4.49 |
2.14 |
2.04 |
1.02 |
1.06 |
| Liczba analityków (Przychody) |
14 |
16 |
23 |
16 |
14 |
15 |
| Liczba analityków (EPS) |
12 |
11 |
17 |
11 |
5 |
4 |
| symbol |
SRPT |
SRPT |
SRPT |
SRPT |
SRPT |
SRPT |